39 funds hold it.Insiders net selling.
Net buying: insiders sold $2.1M and bought $3.2M on the open market in 90 days (SEC Form 4). Congress: both buying and selling, $23K to $170K in total in 180 days.
Analyst target and ratings are on paid plans
See the 12-month consensus target and the buy/hold/sell rating split.
Unlock the full resultsLast report
Oct 1, 2026
Financial period
Q4 FY2026
Earnings per share
$3.18 expected
Q1 FY2027 guidance
$18.95B to $19.60B
$19.39B expected-0.6%at the midpoint
Estimates as of Nov 5, 2026
EPS expected
$3.82 to $4.04
Revenue expected
20 analysts
Last 30 days
Analysts cutting estimates
Estimate drift
Change in 30 days
| Quarter / reported | Earnings per share | Beat or miss | Revenue / income | Revenue vs last year |
|---|---|---|---|---|
| Aug 31, 2026Reported Oct 1, 2026 | $3.29est. $3.18 | +3.36%beat | $18.68BSEC filing | +6.2%from $17.60B |
| May 31, 2026Reported Jun 18, 2026 | $3.80est. $3.71 | +2.46%beat | $18.72BCompany release | +5.6%from $17.73B |
| Feb 28, 2026Reported Mar 19, 2026 | $2.93est. $2.84 | +3.26%beat | $18.04BSEC filing | +8.3%from $16.66B |
| Nov 30, 2025Reported Dec 18, 2025 | $3.94est. $3.72 | +5.87%beat | $18.74BSEC filing | +6.0%from $17.69B |
| Aug 31, 2025Reported Sep 25, 2025 | $3.03est. $2.97 | +2.02%beat | $17.60BSEC filing | +7.3%from $16.41B |
| May 31, 2025Reported Jun 20, 2025 | $3.49est. $3.32 | +5.12%beat | $17.73BSEC filing | +7.7%from $16.47B |
| Feb 28, 2025Reported Mar 20, 2025 | $2.82est. $2.81 | +0.36%in line | $16.66BSEC filing | +5.4%from $15.80B |
| Nov 30, 2024Reported Dec 19, 2024 | $3.59est. $3.42 | +4.97%beat | $17.69BSEC filing | +9.0%from $16.22B |
Earnings per share comes from Yahoo Finance where available, then Alpha Vantage or the company release. Revenue comes from company releases, SEC filings, Alpha Vantage or Yahoo Finance. A beat or miss needs an analyst estimate on the same basis as the reported figure, so quarters without one show none. Non-USD amounts carry their currency code.
| USD | Nov 2025 | Feb 2026 | May 2026 | Aug 2026 |
|---|---|---|---|---|
| What came in | ||||
| Revenue | $18.74B | $18.04B | $18.72B | $18.68B |
| Cost of what it sold | $12.57B | $12.58B | $12.58B | $12.69B |
| Gross profit | $6.17B | $5.46B | $6.13B | $5.98B |
| What it spent | ||||
| Sales and admin | $1.14B | $1.22B | $1.15B | $1.31B |
| Other operating costs | $1.87B | $1.75B | $1.81B | $1.81B |
| Total operating expenses | $3.02B | $2.97B | $2.96B | $3.12B |
| What was left | ||||
| Operating profit | $3.15B | $2.49B | $3.18B | $2.86B |
| Interest on debt | $65.4M | $63.6M | $70.6M | $103.8M |
| Profit before tax | $2.97B | $2.46B | $3.15B | $2.80B |
| Tax | $725.8M | $597.3M | $761.9M | $764.4M |
| Net profit | $2.21B | $1.86B | $2.34B | $1.99B |
| EBITDA | $3.33B | $2.91B | $3.53B | $3.51B |
This stock is in a strong uptrend.
Trend
Strong uptrend
100 / 100
RSI 14
20D volatility
52-week range
20D support
20D resistance
Returns
Price vs moving averages
Volume pace
Coverage is bullish
Accion Labs Recognized as a Global Leader in the ISG Provider Lens® Generative AI Services 2026 Study
Leans bullishNov 3Most companies have moved generative AI beyond pilots. Now they need it to work reliably at scale.
Leans bullishNov 3Emerging Market Quadrant for Integrated Supply Chain AI Agents
Leans bullishNov 3What Invesco S&P 500 Equal Weight ETF (RSP) Bought: Moderna Leads on Oct. 30
Leans bullishNov 3BOC Group Named a Leader in Gartner® Magic Quadrant™ for Enterprise Architecture Tools 2026
Leans bullishNov 3SGV quits PLDT after 24 years over independence issue; PwC’s Isla Lipana takes over Philippine audits
NeutralNov 3How Expected Revenue Growth Will Impact Amdocs (DOX) Investors
NeutralNov 3EPAM Systems, Inc. (EPAM) Stock Price, News, Quote & History
NeutralNov 333 macro signals shaping ACN right now
Unlock sector rotation, regime shifts, and macro event windows tied to this stock.
Unlock the full results